28405177|t|Mapping mitochondrial heteroplasmy in a Leydig tumor by laser capture micro-dissection and cycling temperature capillary electrophoresis
28405177|a|The growth of tumor cells is accompanied by mutations in nuclear and mitochondrial genomes creating marked genetic heterogeneity. Tumors also contain non-tumor cells of various origins. An observed somatic mitochondrial mutation would have occurred in a founding cell and spread through cell division. Micro-anatomical dissection of a tumor coupled with assays for mitochondrial point mutations permits new insights into this growth process. More generally, the ability to detect and trace, at a histological level, somatic mitochondrial mutations in human tissues and tumors, makes these mutations into markers for lineage tracing. A tumor was first sampled by a large punch biopsy and scanned for any significant degree of heteroplasmy in a set of sequences containing known mutational hotspots of the mitochondrial genome. A heteroplasmic tumor was sliced at a 12 μm thickness and placed on membranes. Laser capture micro-dissection was used to take 25000 μm(2) subsamples or spots. After DNA amplification, cycling temperature capillary electrophoresis (CTCE) was used on the laser captured samples to quantify mitochondrial mutant fractions. Of six testicular tumors studied, one, a Leydig tumor, was discovered to carry a detectable degree of heteroplasmy for two separate point mutations: a C → T mutation at bp 64 and a T → C mutation found at bp 152. From this tumor, 381 spots were sampled with laser capture micro-dissection. The ordered distribution of spots exhibited a wide range of fractions of the mutant sequences from 0 to 100% mutant copies. The two mutations co-distributed in the growing tumor indicating they were present on the same genome copies in the founding cell. Laser capture micro-dissection of sliced tumor samples coupled with CTCE -based point mutation assays provides an effective and practical means to obtain maps of mitochondrial mutational heteroplasmy within human tumors.
28405177	0	34	Mapping mitochondrial heteroplasmy	T058	UMLS:C3865703
28405177	40	52	Leydig tumor	T038	UMLS:C0023601
28405177	56	86	laser capture micro-dissection	T058	UMLS:C1113652
28405177	91	136	cycling temperature capillary electrophoresis	T058	UMLS:C0201699
28405177	141	147	growth	T038	UMLS:C1621966
28405177	151	162	tumor cells	T017	UMLS:C0431085
28405177	181	190	mutations	T038	UMLS:C0026882
28405177	194	201	nuclear	T082	UMLS:C0521447
28405177	206	227	mitochondrial genomes	T017	UMLS:C1819716
28405177	267	273	Tumors	T038	UMLS:C0027651
28405177	287	302	non-tumor cells	T033	UMLS:C0243095
28405177	343	365	mitochondrial mutation	T038	UMLS:C2315666
28405177	391	404	founding cell	T017	UMLS:C0007634
28405177	424	437	cell division	T038	UMLS:C0007590
28405177	439	466	Micro-anatomical dissection	T058	UMLS:C1113652
28405177	472	477	tumor	T038	UMLS:C0027651
28405177	491	497	assays	T058	UMLS:C1510438
28405177	502	531	mitochondrial point mutations	T038	UMLS:C2315666
28405177	563	569	growth	T038	UMLS:C1621966
28405177	610	616	detect	T033	UMLS:C0442726
28405177	661	684	mitochondrial mutations	T038	UMLS:C2315666
28405177	688	701	human tissues	T017	UMLS:C0440744
28405177	706	712	tumors	T038	UMLS:C0027651
28405177	726	735	mutations	T038	UMLS:C0026882
28405177	741	748	markers	T201	UMLS:C0005516
28405177	772	777	tumor	T038	UMLS:C0027651
28405177	788	795	sampled	T058	UMLS:C0441621
28405177	807	819	punch biopsy	T058	UMLS:C0184924
28405177	824	831	scanned	T058	UMLS:C0441633
28405177	887	896	sequences	T082	UMLS:C0162326
28405177	914	933	mutational hotspots	T082	UMLS:C2986491
28405177	941	961	mitochondrial genome	T017	UMLS:C1819716
28405177	979	984	tumor	T038	UMLS:C0027651
28405177	1031	1040	membranes	T017	UMLS:C0596901
28405177	1042	1072	Laser capture micro-dissection	T058	UMLS:C1113652
28405177	1129	1146	DNA amplification	T038	UMLS:C0683230
28405177	1148	1193	cycling temperature capillary electrophoresis	T058	UMLS:C0201699
28405177	1195	1199	CTCE	T058	UMLS:C0201699
28405177	1217	1231	laser captured	T033	UMLS:C0243095
28405177	1252	1265	mitochondrial	T017	UMLS:C0026237
28405177	1266	1272	mutant	T038	UMLS:C0596988
28405177	1291	1308	testicular tumors	T038	UMLS:C0039590
28405177	1325	1337	Leydig tumor	T038	UMLS:C0023601
28405177	1365	1375	detectable	T201	UMLS:C3830527
28405177	1416	1431	point mutations	T038	UMLS:C0162735
28405177	1435	1449	C → T mutation	T038	UMLS:C0026882
28405177	1465	1479	T → C mutation	T038	UMLS:C0026882
28405177	1507	1512	tumor	T038	UMLS:C0027651
28405177	1529	1536	sampled	T058	UMLS:C0441621
28405177	1542	1572	laser capture micro-dissection	T058	UMLS:C1113652
28405177	1651	1657	mutant	T038	UMLS:C0596988
28405177	1658	1667	sequences	T082	UMLS:C0162326
28405177	1683	1689	mutant	T038	UMLS:C0596988
28405177	1706	1715	mutations	T038	UMLS:C0026882
28405177	1738	1745	growing	T038	UMLS:C1621966
28405177	1746	1751	tumor	T038	UMLS:C0027651
28405177	1773	1780	present	T033	UMLS:C0150312
28405177	1793	1799	genome	T017	UMLS:C0017428
28405177	1814	1827	founding cell	T017	UMLS:C0007634
28405177	1829	1859	Laser capture micro-dissection	T058	UMLS:C1113652
28405177	1870	1875	tumor	T038	UMLS:C0027651
28405177	1897	1901	CTCE	T058	UMLS:C0201699
28405177	1909	1923	point mutation	T038	UMLS:C0162735
28405177	1924	1930	assays	T058	UMLS:C1510438
28405177	1983	1987	maps	T062	UMLS:C0079435
28405177	1991	2004	mitochondrial	T017	UMLS:C0026237
28405177	2005	2015	mutational	T038	UMLS:C0026882
28405177	2036	2041	human	T204	UMLS:C0086418
28405177	2042	2048	tumors	T038	UMLS:C0027651